BEIJING, May 16, 2012 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or
the "Company"), an emerging leader in the development, assembly,
marketing and sale of medical devices and homecare medical
products, today announced that the Company has established a
wholly-owned U.S. subsidiary, BreathCare, LLC ("BreathCare"), which
is based in Illinois. BreathCare will be functioning as an
operation center for Dehaier's International focused business,
which includes, but is not limited to, product registration,
product marketing, and evaluating potential merger and acquisition
targets.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
The Company's goal is to expand into the United States by establishing a
distribution network through distribution agreements and the
establishment of a direct sales force. BreathCare was formed as a
result of the Company's growing business prospects in the
U.S., Canada, Central and
South America, along with
Dehaier's desire to provide enhanced service and support levels to
its expanding customer base in these countries. Currently,
BreathCare LLC is preparing to seek approval from the Food and Drug
Administration ("FDA") for its homecare products, including CPAP,
oxygen concentrator, sleep diagnostic devices and oxygen
inhalator.
Mr. Ping Chen, Chairman and Chief
Executive Officer of Dehaier Medical stated, "The establishment of
an overseas office is a major milestone in Dehaier's growth. We
expect to expand our product base to serve these international
markets, which we believe is an enormous market for our Company's
unique respiratory and homecare medical products. Early this
year, we received Conformite Europeenne (CE) certification for our
sleep diagnostic devices and air compressors. Opening a US
based operation is yet another important milestone in our goal to
make Dehaier's products available worldwide and the successful
continuation of our expansion strategy."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent
Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents and five software
copyrights; additionally Dehaier has two pending software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's membership in the
Zhongguancun Association and the meaning of and retention of any
ratings granted to Dehaier (including any factors affecting such
ratings). These statements are subject to uncertainties and risks
including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com
In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com
SOURCE Dehaier Medical Systems Ltd.